Author:
Han David K.,Eng Jimmy,Zhou Huilin,Aebersold Ruedi
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference34 articles.
1. Oseroff, A.R., Robbins, P.W. & Burger, M.M. Cell surface membrane: biochemical aspects and biophysical probes. Annual Rev. Biochem. 42, 647–682 (1973).
2. Liu, E. et al. The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene 7, 1027–1032 (1992).
3. Shak, S. Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group. Semin. Oncol. 26, 71–77 (1999).
4. Eccles, S.A. Monoclonal antibodies targeting cancer: “magic bullets” or just the trigger? Breast Cancer Res. 3, 86–90 (2001).
5. Drews, J. Research and development. Basic science and pharmaceutical innovation. Nat. Biotechnol. 17, 406–408 (1999).
Cited by
838 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献